NeurologyLive® Top Expert Interviews: December 2021

The NeurologyLive^® team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.

Among these included conversations on the costs associated with Alzheimer disease drug development with Jeffrey Cummings, MD, ScD; the recent approval of a new agent for generalized myasthenia gravis with James F. Howard, MD; the treatment of migraine in the emergency department with Anne-Maree Kelly, MD; a recent study that assessed the effectiveness of educational sleep medicine “boot camps” with Anita Shelgikar, MD, MHPE; and the highlights from the American Epilepsy Society Annual Meeting with Imad Najm, MD.

Click through the slides to see and read more from each expert’s exclusive conversation with NeurologyLive^® in December 2021.

To hear more insight from experts in the clinical care of patients and leading researchers in neurology, check out more of NeurologyLive^®'s videos.

REFERENCES
1. Cummings JL, Goldman DP, Simmons-Stern NR, Ponton E. The costs of developing treatments for Alzheimer disease: a retrospective exploration. Alzheimer Dement. Published online September 28, 2021. doi:10.1002/alz.12450
2. FDA Approves New Treatment for Myasthenia Gravis. News release. FDA. December 17, 2021. Accessed January 13, 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-myasthenia-gravis
3. Kelly AM, Kuan WS, Chu KH, et al. Epidemiology, investigation, management, and outcome of headache in emergency departments (HEAD study)–a multinational observational study. Headache. 2021;61(10):1539-1552. doi:10.1111/head.14230?
4. Wappel SR, Scharf SM, Cohen L, et al. Improving sleep medicine education among health professions trainees. J Clin Sleep Med. 2021;17(12):2461-2466. doi:10.5664/jcsm.9456